It has also been reported that increased levels of CXCL9/10 were associated with increased numbers of tumor-infiltrating CD8+ T cells and CXCL9/10 were related with efficiency of immune therapy by blocking PD-L1 and PD-1 interaction (34). Here, CD8A is linked to neoplasm.